Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial

E-ISSN： 1538-7836|13|12|2187-2191

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.12, 2015-12, pp. : 2187-2191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Venous Thromboembolism in Cancer Patients

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 66-70

Karger

Access to resources Recommend Favorite

Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 5, 2015-05 ,pp. : 880-883

John Wiley & Sons Inc

Access to resources Recommend Favorite

Practice Patterns for Prophylaxis and Treatment of Venous Thromboembolism in German Cancer Patients

Oncology Research and Treatment, Vol. 39, Iss. 4, 2016-03 ,pp. : 194-201

Karger

Access to resources Recommend Favorite

Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai‐VTE trial

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 9, 2015-09 ,pp. : 1606-1614

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery

By Martin Michelle T. Nutescu Edith A.

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2123-2131

Informa Healthcare

Access to resources Recommend Favorite